The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Strategies for Treatment-Experienced HIVersStrategies for Treatment-Experienced HIVers
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

New Medication
Oct 19, 2006

How well does the new medication ATRIPLA work. It's taken once a day

Response from Dr. Daar

Atripla is a combination pill that includes tenofovir (Viread), emtricitabine (FTC, Emtriva) and efavirenz (sustiva). It is higly effective in the majority of people who are starting therapy for the first time or have no underlying drug resistant virus. It is generally taken as one pill per day at bed time and in clinical trials results in viral loads below the limits of detection in more than 80% of people who consistently take their medications. It is not right for everyone and there are select side effects that people need to be aware of and monitored for. In addition, women who are pregnant or might get pregnant should not use this medication. As is the case with all HIV medications, the best thing for any individual to do is discuss with their provider what is the optimal regimen for them and be followed closely for response and toxicity once treatment is initiated.

Best, Eric

Gall stones and Reyataz

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint